Integrated Network Pharmacology and GC-MS–Based Metabolomics to Investigate the Effect of Xiang-Su Volatile Oil Against Menopausal Depression

Menopausal depression perplexes a great number of women in later life. Xiangfu-Zisu (Xiang-Su), a traditional Chinese herbal pair composed of rhizomes of Cyperus rotundus L. (Xiangfu) and leaves of Perilla frutescens (L.) Britt. (Zisu), is frequently reported with antidepressant-like effects. The vo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yao Li, Xinyi Yang, Shanshan Chen, Lei Wu, Jinyong Zhou, Keke Jia, Wenzheng Ju
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/fe16944387b64ec58b879684fefe5c11
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fe16944387b64ec58b879684fefe5c11
record_format dspace
spelling oai:doaj.org-article:fe16944387b64ec58b879684fefe5c112021-12-02T11:20:39ZIntegrated Network Pharmacology and GC-MS–Based Metabolomics to Investigate the Effect of Xiang-Su Volatile Oil Against Menopausal Depression1663-981210.3389/fphar.2021.765638https://doaj.org/article/fe16944387b64ec58b879684fefe5c112021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.765638/fullhttps://doaj.org/toc/1663-9812Menopausal depression perplexes a great number of women in later life. Xiangfu-Zisu (Xiang-Su), a traditional Chinese herbal pair composed of rhizomes of Cyperus rotundus L. (Xiangfu) and leaves of Perilla frutescens (L.) Britt. (Zisu), is frequently reported with antidepressant-like effects. The volatile oil from Xiangfu and Zisu has shown good antidepressant action, but its mechanism is still unclear. This study aimed to investigate the pharmacological mechanism of Xiang-Su (XS) volatile oil against menopausal depression through gas chromatography–mass spectrometry (GC-MS)-based network pharmacology and metabolomics. First, ADME screening was performed on actual detected components of XS volatile oil to obtain active constituents, and then duplicates of active constituent–related targets and menopausal depression–related targets were collected. These duplicates were considered as targets for XS volatile oil against menopausal depression, followed by GO and KEGG enrichment analyses. It showed that a total of 64 compounds were identified in XS volatile oil, and 38 active compounds were screened out. 42 overlapping genes between 144 compound-related genes and 780 menopausal depression–related genes were obtained. Results showed that targets of SLC6A4 and SLC6A3, regulation of serotonergic and dopaminergic synapses, were involved in the antidepressant mechanism of XS volatile oil. Next, antidepressant-like effect of XS volatile oil was validated in menopausal rats by ovariectomy (OVX) combined with chronic unpredictable mild stress (CUMS). Behavioral tests, biochemical analysis, and GC-MS–based non-targeted plasma metabolomics were employed to validate the antidepressant effect of XS volatile oil. Experimental evidence demonstrated that XS volatile oil reversed behavioral parameters in the sucrose preference test (SPT), open-field test (OFT), forced swim test (FST), and serum estradiol levels in OVX rats. Furthermore, results of metabolomics indicated that XS volatile oil mainly acts on regulating metabolic pathways of phenylalanine, tyrosine and tryptophan biosynthesis, tyrosine metabolism, and tryptophan metabolism, which were corresponding with the above-predicted results. These data suggest that network pharmacology combined with metabolomics provides deep insight into the antidepressant effect of XS volatile oil, which includes regulating key targets like SLC6A4 and SLC6A3, and pathways of serotonergic and dopaminergic synapses.Yao LiXinyi YangShanshan ChenLei WuJinyong ZhouKeke JiaKeke JiaWenzheng JuFrontiers Media S.A.articleXiang-Su volatile oilmenopausedepressionnetwork pharmacologymetabolomicsTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Xiang-Su volatile oil
menopause
depression
network pharmacology
metabolomics
Therapeutics. Pharmacology
RM1-950
spellingShingle Xiang-Su volatile oil
menopause
depression
network pharmacology
metabolomics
Therapeutics. Pharmacology
RM1-950
Yao Li
Xinyi Yang
Shanshan Chen
Lei Wu
Jinyong Zhou
Keke Jia
Keke Jia
Wenzheng Ju
Integrated Network Pharmacology and GC-MS–Based Metabolomics to Investigate the Effect of Xiang-Su Volatile Oil Against Menopausal Depression
description Menopausal depression perplexes a great number of women in later life. Xiangfu-Zisu (Xiang-Su), a traditional Chinese herbal pair composed of rhizomes of Cyperus rotundus L. (Xiangfu) and leaves of Perilla frutescens (L.) Britt. (Zisu), is frequently reported with antidepressant-like effects. The volatile oil from Xiangfu and Zisu has shown good antidepressant action, but its mechanism is still unclear. This study aimed to investigate the pharmacological mechanism of Xiang-Su (XS) volatile oil against menopausal depression through gas chromatography–mass spectrometry (GC-MS)-based network pharmacology and metabolomics. First, ADME screening was performed on actual detected components of XS volatile oil to obtain active constituents, and then duplicates of active constituent–related targets and menopausal depression–related targets were collected. These duplicates were considered as targets for XS volatile oil against menopausal depression, followed by GO and KEGG enrichment analyses. It showed that a total of 64 compounds were identified in XS volatile oil, and 38 active compounds were screened out. 42 overlapping genes between 144 compound-related genes and 780 menopausal depression–related genes were obtained. Results showed that targets of SLC6A4 and SLC6A3, regulation of serotonergic and dopaminergic synapses, were involved in the antidepressant mechanism of XS volatile oil. Next, antidepressant-like effect of XS volatile oil was validated in menopausal rats by ovariectomy (OVX) combined with chronic unpredictable mild stress (CUMS). Behavioral tests, biochemical analysis, and GC-MS–based non-targeted plasma metabolomics were employed to validate the antidepressant effect of XS volatile oil. Experimental evidence demonstrated that XS volatile oil reversed behavioral parameters in the sucrose preference test (SPT), open-field test (OFT), forced swim test (FST), and serum estradiol levels in OVX rats. Furthermore, results of metabolomics indicated that XS volatile oil mainly acts on regulating metabolic pathways of phenylalanine, tyrosine and tryptophan biosynthesis, tyrosine metabolism, and tryptophan metabolism, which were corresponding with the above-predicted results. These data suggest that network pharmacology combined with metabolomics provides deep insight into the antidepressant effect of XS volatile oil, which includes regulating key targets like SLC6A4 and SLC6A3, and pathways of serotonergic and dopaminergic synapses.
format article
author Yao Li
Xinyi Yang
Shanshan Chen
Lei Wu
Jinyong Zhou
Keke Jia
Keke Jia
Wenzheng Ju
author_facet Yao Li
Xinyi Yang
Shanshan Chen
Lei Wu
Jinyong Zhou
Keke Jia
Keke Jia
Wenzheng Ju
author_sort Yao Li
title Integrated Network Pharmacology and GC-MS–Based Metabolomics to Investigate the Effect of Xiang-Su Volatile Oil Against Menopausal Depression
title_short Integrated Network Pharmacology and GC-MS–Based Metabolomics to Investigate the Effect of Xiang-Su Volatile Oil Against Menopausal Depression
title_full Integrated Network Pharmacology and GC-MS–Based Metabolomics to Investigate the Effect of Xiang-Su Volatile Oil Against Menopausal Depression
title_fullStr Integrated Network Pharmacology and GC-MS–Based Metabolomics to Investigate the Effect of Xiang-Su Volatile Oil Against Menopausal Depression
title_full_unstemmed Integrated Network Pharmacology and GC-MS–Based Metabolomics to Investigate the Effect of Xiang-Su Volatile Oil Against Menopausal Depression
title_sort integrated network pharmacology and gc-ms–based metabolomics to investigate the effect of xiang-su volatile oil against menopausal depression
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/fe16944387b64ec58b879684fefe5c11
work_keys_str_mv AT yaoli integratednetworkpharmacologyandgcmsbasedmetabolomicstoinvestigatetheeffectofxiangsuvolatileoilagainstmenopausaldepression
AT xinyiyang integratednetworkpharmacologyandgcmsbasedmetabolomicstoinvestigatetheeffectofxiangsuvolatileoilagainstmenopausaldepression
AT shanshanchen integratednetworkpharmacologyandgcmsbasedmetabolomicstoinvestigatetheeffectofxiangsuvolatileoilagainstmenopausaldepression
AT leiwu integratednetworkpharmacologyandgcmsbasedmetabolomicstoinvestigatetheeffectofxiangsuvolatileoilagainstmenopausaldepression
AT jinyongzhou integratednetworkpharmacologyandgcmsbasedmetabolomicstoinvestigatetheeffectofxiangsuvolatileoilagainstmenopausaldepression
AT kekejia integratednetworkpharmacologyandgcmsbasedmetabolomicstoinvestigatetheeffectofxiangsuvolatileoilagainstmenopausaldepression
AT kekejia integratednetworkpharmacologyandgcmsbasedmetabolomicstoinvestigatetheeffectofxiangsuvolatileoilagainstmenopausaldepression
AT wenzhengju integratednetworkpharmacologyandgcmsbasedmetabolomicstoinvestigatetheeffectofxiangsuvolatileoilagainstmenopausaldepression
_version_ 1718396035218276352